In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other factors play a significant role in repeating outbreaks.
|Videos|December 1, 2017
What is Needed to Achieve an HIV & AIDS-Free World by 2030?
Author(s)Contagion® Editorial Staff
Jake Glaser shares what is needed to achieve the Fast-Track strategy to end the AIDS epidemic by 2030.
Advertisement
Jake Glaser, founder, Modern Advocate; ambassador, Elizabeth Glaser Pediatric Foundation and member, End AIDS Coalition, shares what is needed to achieve the Fast-Track strategy to end the AIDS epidemic by 2030.
Interview Transcript (modified slightly for readability):
“I would say that the one thing that would hinder our ability to overcome HIV & AIDS, and to actually achieve a world free of HIV & AIDS by 2030, would be a breakdown of communication and collaboration. We need to continue to grow our efforts in teamwork. We need to be able to grow our efforts in consolidating funding and putting it towards a unilateral strategy. And, [we need to] be able to speak to the world with a message that is being sent through all respective organizations of the world. We need one unified marketing strategy. To get this done, we have to work together. The only way that it’s not going to get done is if we don’t work together.
I think that everyone in the world understands that everything works better when we work together. If you try to set out and accomplish anything alone in life, you’re going to be incredibly challenged, and you’re going to feel alone in the experience. [Therefore,] I would suggest that everyone who hears this, that’s listening to your broadcast, that is part of your community, [to know that] teamwork is everything. You have to find your neighbors, you have to find your friends, you have to find your partners, and you have to find a way to be able to work together to educate, to inspire, and to be a part of creating the solution.”
Advertisement
Related to this article
In the second episode of the series with Perry N. Halkitis, PhD, MS, MPH, he brings his personal experience to this topic and questions whether there should be a shift in who manages the primary care needs of these patients.
Here is a review of glucagon-like peptide-1 receptor agonist use in people with HIV.
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
New gyrA testing guides ciprofloxacin use for gonorrhea, cutting ceftriaxone reliance while tackling resistance, access, and FDA hurdles.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.